阿尔茨海默病中 tau 的复杂性。
The complexity of tau in Alzheimer's disease.
机构信息
Helen and Robert Appel Alzheimer's Disease Research Institute, Brain and Mind Research Institute, Weill Cornell Medicine, New York, USA.
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, USA.
出版信息
Neurosci Lett. 2019 Jul 13;705:183-194. doi: 10.1016/j.neulet.2019.04.022. Epub 2019 Apr 25.
Abstract
Alzheimer's disease (AD) is characterized by two major pathological lesions in the brain, amyloid plaques and neurofibrillary tangles (NFTs) composed mainly of amyloid-β (Aβ) peptides and hyperphosphorylated tau, respectively. Although accumulation of toxic Aβ species in the brain has been proposed as one of the important early events in AD, continued lack of success of clinical trials based on Aβ-targeting drugs has triggered the field to seek out alternative disease mechanisms and related therapeutic strategies. One of the new approaches is to uncover novel roles of pathological tau during disease progression. This review will primarily focus on recent advances in understanding the contributions of tau to AD.
摘要
阿尔茨海默病（AD）的特征是大脑中有两种主要的病理病变，即由淀粉样β（Aβ）肽和过度磷酸化的 tau 分别组成的淀粉样斑块和神经原纤维缠结（NFTs）。尽管脑内有毒性 Aβ 物质的积累被认为是 AD 的重要早期事件之一，但基于 Aβ 靶向药物的临床试验的持续失败促使该领域寻求替代疾病机制和相关治疗策略。一种新方法是揭示病理 tau 在疾病进展过程中的新作用。本综述将主要关注对 tau 在 AD 中的作用的最新理解进展。
相似文献
1
The complexity of tau in Alzheimer's disease.阿尔茨海默病中 tau 的复杂性。
Neurosci Lett. 2019 Jul 13;705:183-194. doi: 10.1016/j.neulet.2019.04.022. Epub 2019 Apr 25.
2
Tau Proteins and Tauopathies in Alzheimer's Disease.阿尔茨海默病中的 Tau 蛋白和 Tau 病。
Cell Mol Neurobiol. 2018 Jul;38(5):965-980. doi: 10.1007/s10571-017-0574-1. Epub 2018 Jan 3.
3
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.突触线粒体：阿尔茨海默病中淀粉样β和tau 的早期靶标。
J Alzheimers Dis. 2021;84(4):1391-1414. doi: 10.3233/JAD-215139.
4
Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation.阿尔茨海默病中的 Tau 和神经炎症：相互作用机制及临床转化。
J Neuroinflammation. 2023 Jul 14;20(1):165. doi: 10.1186/s12974-023-02853-3.
5
A role for tau at the synapse in Alzheimer's disease pathogenesis.tau 在阿尔茨海默病发病机制中的突触作用。
Neuropharmacology. 2014 Jan;76 Pt A:1-8. doi: 10.1016/j.neuropharm.2013.09.018. Epub 2013 Sep 25.
6
Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.新型药物通过影响 tau 蛋白行为治疗阿尔茨海默病和 tau 相关神经退行性疾病。
Curr Alzheimer Res. 2011 Sep;8(6):678-85. doi: 10.2174/156720511796717122.
7
Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target.阿尔茨海默病中的 Tau：病理改变与有吸引力的治疗靶点。
Curr Med Sci. 2020 Dec;40(6):1009-1021. doi: 10.1007/s11596-020-2282-1. Epub 2021 Jan 11.
8
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.Aβ 与 Tau 在阿尔茨海默病发病机制中的相互作用。
Int J Biol Sci. 2021 May 27;17(9):2181-2192. doi: 10.7150/ijbs.57078. eCollection 2021.
9
Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration.阿尔茨海默病和其他 Tau 病：探索药用植物衍生化合物缓解 Tau 介导的神经退行性变的疗效。
Curr Mol Pharmacol. 2022;15(2):361-379. doi: 10.2174/1874467214666210906125318.
10
Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.针对阿尔茨海默病和相关tau 病的 tau 定向药物发现：tau 组装抑制剂的重点。
Exp Neurol. 2010 Jun;223(2):304-10. doi: 10.1016/j.expneurol.2009.08.031. Epub 2009 Sep 8.
引用本文的文献
1
Integrated Gut Microbiota, Metabolomics, and Network Pharmacology to Investigate the Anti-Alzheimer's Mechanism of Tripterygium Glycoside.整合肠道微生物群、代谢组学和网络药理学以研究雷公藤多苷抗阿尔茨海默病的机制
Neuropsychiatr Dis Treat. 2025 Sep 3;21:1911-1933. doi: 10.2147/NDT.S537129. eCollection 2025.
2
The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicine.氧化三甲胺在疾病发病机制中的作用及中药的治疗潜力。
Front Pharmacol. 2025 Jul 24;16:1592524. doi: 10.3389/fphar.2025.1592524. eCollection 2025.
3
4
Unveiling the therapeutic potential of natural products in Alzheimer's disease: insights from , , and clinical studies.揭示天然产物在阿尔茨海默病中的治疗潜力：来自……及临床研究的见解
Front Pharmacol. 2025 Jun 23;16:1601712. doi: 10.3389/fphar.2025.1601712. eCollection 2025.
5
Epigenetic Clocks and Their Prospective Application in the Complex Landscape of Aging and Alzheimer's Disease.表观遗传时钟及其在衰老和阿尔茨海默病复杂领域中的潜在应用。
Genes (Basel). 2025 May 30;16(6):679. doi: 10.3390/genes16060679.
6
Nanoplatforms Targeting Intrinsically Disordered Protein Aggregation for Translational Neuroscience Applications.用于转化神经科学应用的靶向内在无序蛋白聚集的纳米平台。
Nanomaterials (Basel). 2025 May 8;15(10):704. doi: 10.3390/nano15100704.
7
Applications of event-related potentials in Alzheimer's disease: a systematic review and analysis.事件相关电位在阿尔茨海默病中的应用：系统评价与分析
Front Aging Neurosci. 2025 May 2;17:1513049. doi: 10.3389/fnagi.2025.1513049. eCollection 2025.
8
Acanthopanax Senticosus Saponins Prevent Cognitive Decline in Rats with Alzheimer's Disease.刺五加皂苷可预防阿尔茨海默病大鼠的认知衰退。
Int J Mol Sci. 2025 Apr 14;26(8):3715. doi: 10.3390/ijms26083715.
9
Mitochondria and Endoplasmic Reticulum Contact Site as a Regulator of Proteostatic Stress Responses in Neurodegenerative Diseases.线粒体与内质网接触位点作为神经退行性疾病中蛋白质稳态应激反应的调节因子
Bioessays. 2025 May 4:e70016. doi: 10.1002/bies.70016.
10
Association Between and Alzheimer's Disease: A Comprehensive Review.[具体内容]与阿尔茨海默病之间的关联：一项全面综述
Infect Drug Resist. 2025 Apr 25;18:2119-2136. doi: 10.2147/IDR.S491628. eCollection 2025.
本文引用的文献
1
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.单细胞分辨率下的小鼠和人类小胶质细胞的时空异质性。
Nature. 2019 Feb;566(7744):388-392. doi: 10.1038/s41586-019-0924-x. Epub 2019 Feb 13.
2
Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.聚集的 Tau 激活 NLRP3-ASC 炎症小体，加剧体内外源性和非外源性 Tau 病理。
Acta Neuropathol. 2019 Apr;137(4):599-617. doi: 10.1007/s00401-018-01957-y. Epub 2019 Feb 5.
3
Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry.基于多重单细胞质谱流式细胞术的人类小胶质细胞区域异质性和表型。
Nat Neurosci. 2019 Jan;22(1):78-90. doi: 10.1038/s41593-018-0290-2. Epub 2018 Dec 17.
4
Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.对 rTg4510 tau 转基因动物模型中病理 tau 扰动引发的小胶质细胞激活的分子机制进行全基因组 RNAseq 研究。
Mol Neurodegener. 2018 Dec 17;13(1):65. doi: 10.1186/s13024-018-0296-y.
5
Secretion of Tau via an Unconventional Non-vesicular Mechanism.通过非常规非囊泡机制分泌 Tau。
Cell Rep. 2018 Nov 20;25(8):2027-2035.e4. doi: 10.1016/j.celrep.2018.10.078.
6
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease.补体 C3aR 失活可减轻 Tau 病理学并逆转 Tau 病模型和阿尔茨海默病中失调的免疫网络。
Neuron. 2018 Dec 19;100(6):1337-1353.e5. doi: 10.1016/j.neuron.2018.10.031. Epub 2018 Nov 8.
7
Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.tau 病中的突触蛋白组变化及 C1q 抗体对 tau 诱导的突触丢失的挽救作用。
Neuron. 2018 Dec 19;100(6):1322-1336.e7. doi: 10.1016/j.neuron.2018.10.014. Epub 2018 Nov 1.
8
Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病中的脑脊液磷酸化tau蛋白、类视锥蛋白样蛋白1和几丁质酶3样蛋白1
Transl Neurodegener. 2018 Sep 10;7:23. doi: 10.1186/s40035-018-0127-7. eCollection 2018.
9
Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau.散发性阿尔茨海默病的综合治疗方法：在一种tau 病小鼠模型中，TYROBP 的缺乏减少了 C1q 并使临床表型正常化，同时增加了 tau 的扩散和磷酸化状态。
Mol Psychiatry. 2019 Sep;24(9):1383-1397. doi: 10.1038/s41380-018-0258-3. Epub 2018 Oct 3.
10
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline.清除衰老的神经胶质细胞可预防tau 依赖性病变和认知能力下降。
Nature. 2018 Oct;562(7728):578-582. doi: 10.1038/s41586-018-0543-y. Epub 2018 Sep 19.
Zotero 插件